UNIPHARMA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 TWD | +8.13% |
|
+33.08% | +16.89% |
| Apr. 24 | UniPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | UniPharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2022 | 128M 3.92M | Sales 2023 | 103M 3.16M | Capitalization | 525M 16.09M |
|---|---|---|---|---|---|
| Net income 2022 | -6M -184K | Net income 2023 | -21M -643K | EV / Sales 2022 | 3.06 x |
| Net cash position 2022 | 159M 4.86M | Net cash position 2023 | 167M 5.11M | EV / Sales 2023 | 3.47 x |
| P/E ratio 2022 |
-85.3
x | P/E ratio 2023 |
-24.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.78% |
More Fundamentals
* Assessed data
More news
| 1 day | +8.13% | ||
| 1 week | +33.08% | ||
| Current month | +5.81% | ||
| 1 month | +39.52% | ||
| 3 months | +27.68% | ||
| 6 months | +16.89% | ||
| Current year | +16.89% |
1 week
15.60
19.65
1 month
11.8019.65
Current year
11.8019.65
1 year
11.8021.05
3 years
10.4530.60
5 years
6.1993.00
10 years
6.1993.00
| Managers | Title | Age | Since |
|---|---|---|---|
Liang Kuang Lin
CEO | Chief Executive Officer | - | 05-07-24 |
Hui Ling Chen
DFI | Director of Finance/CFO | - | 14-10-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cheng Chen
CHM | Chairman | 69 | 15-06-04 |
Liang Kuang Lin
CEO | Chief Executive Officer | - | 05-07-24 |
Chia Lin Wang
BRD | Director/Board Member | - | 17-06-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-02 | 17.3 | +8.13% | 660,611 |
| 24-07-01 | 16 | -2.14% | 251,901 |
| 24-06-28 | 16.35 | -9.67% | 656,231 |
| 24-06-27 | 18.1 | -4.23% | 1,538,714 |
| 24-06-26 | 18.9 | +45.38% | 1,616,044 |
End-of-day quote Taipei Exchange, July 01, 2024
More quotes
UNI PHARMA CO., LTD. is a Taiwan-based company maily engaged in wholesale of diagnostdic reagents, medical equipment and medicines. The Company's main products include Onko-SureDR-70, for monitoring and marking after Colorectal cancer surgery;Cervi-M, using in detection of DNA methylation for Cervical cancer; EZ Detect, home use fecal occult blood test paper;RFA, cancer treatment medical equipment;Bain inj, a kind of morphine analgesics;Naloxone inj, antidote for morphine drugs overdose;Esmolol inj, ultrashort type B sympathetic nerve blockers;Fomepizole inj, a kind of alcoholic poisoning antidote;and Tambocor tab, a kind of arrhythmia treatment.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.89% | 17.43M | |
| -13.75% | 272M | |
| +7.23% | 190M | |
| +49.40% | 83.59M | |
| +26.13% | 77.74M |
- Stock Market
- Equities
- 6621 Stock
